Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Coughlin Timothy P
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   190,353    

Indirect Shares

   62,390      
Direct Value   $19,505,789    

Indirect Value

   $210,841      
Total Shares   252,743      
Total Value   $19,716,630      


Neurocrine Biosciences Inc $19,179,338 Travere Therapeutics, Inc $289,850 Fate Therapeutics Inc $36,600 Neurocrine Biosciences Inc $19,179,338 Travere Therapeutics, Inc $289,850 Fate Therapeutics Inc $36,600
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -74.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX Chief Financial Officer 2017-02-06 137,961 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2023-05-17 42,500 2015-03-31 0    Premium*  
            Fate Therapeutics Inc FATE Director 2022-06-09 9,892 2022-06-09 56,390    Premium*  
            aTyr Pharma Inc LIFE Director 2023-05-17 0 2023-05-17 6,000    Premium*  
* Premium Members only  

Records found :    57         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2006-09-18 3 IO $0.00 $0 D/D 0 228 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2008-02-12 4 AS $4.96 $39,450 D/D (7,857) 11,704 0 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2009-01-13 4 AS $3.39 $28,648 D/D (8,463) 22,574 0 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2009-03-30 4 AS $3.43 $41,537 D/D (12,117) 43,790 0 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2010-01-12 4 AS $2.52 $21,951 D/D (8,697) 54,427 0 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2010-03-01 4 AS $2.53 $31,972 D/D (12,650) 75,110 0 -
NBIX Neurocrine Biosciences In... VP and Chief Financial Officer   •       –      –    2011-02-28 4 AS $6.83 $84,104 D/D (12,320) 96,124 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2013-08-05 4 AS $14.99 $164,365 D/D (10,965) 96,124 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2013-08-21 4 AS $15.05 $286,477 D/D (19,035) 96,124 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-01-07 4 AS $16.75 $1,172,500 D/D (70,000) 96,124 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-01-10 4 AS $18.56 $32,480 D/D (1,750) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-10-28 4 AS $18.00 $180,000 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-10-30 4 AS $18.62 $186,200 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-10-31 4 AS $19.00 $190,000 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-11-28 4 AS $20.14 $201,400 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-10 4 OE $2.59 $77,100 D/D 20,000 107,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-10 4 AS $21.00 $429,500 D/D (20,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-18 4 OE $2.59 $51,800 D/D 20,000 117,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-18 4 AS $23.11 $463,600 D/D (20,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-19 4 OE $2.59 $25,900 D/D 10,000 107,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2014-12-19 4 AS $24.02 $240,200 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2015-01-08 4 AS $27.25 $272,500 D/D (10,000) 97,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2015-01-08 4 OE $2.59 $25,900 D/D 10,000 107,874 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2015-01-12 4 AS $28.37 $49,648 D/D (1,750) 99,624 0 -
NBIX Neurocrine Biosciences In... Chief Financial Officer   •       –      –    2015-01-16 4 AS $30.81 $53,918 D/D (1,750) 101,374 0 -
  57  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us